Animal Health



Located among the world’s largest concentration of animal health and nutrition companies, KBA invests in production and companion animal pharmaceutical and product innovations.

KBA will consider investment opportunities in the following areas and technologies:

  • Alternatives to antibiotics for growth promotion or therapeutic use
  • Address growing global demand for animal protein
  • Improve pre and post harvest food safety
  • Novel drug and vaccine delivery systems
  • Improve production efficiency / lower costs
      • Feed conversion
      • Product quality
  • Wearable technologies
  • Data and mobile platforms

Portfolio Story

Portfolio Story Placeholder

Aratana Therapeutics Inc. (NASDAQ:PETX) in-licenses compounds developed for human health and then develops and commercializes them as regulatory-approved therapeutics for companion animals. Aratana’s model allows it to move quickly, developing animal health pharmaceutical technologies at competitively lower costs to serve the unmet need of products approved to specifically manage pets’ health safely and effectively.

Learn more